-
Blog BLOG
-
Product Center BRAND DYNAMICS
-
Investor INVESTOR RELATIONS
-
Contact Us CONTACT
-
Supervise SUPERVISION
Deep into the Qiangtang hinterland: Healthy Yuan & Lizhu Group's chronic disease public welfare supports the red Gaize
Published Time:
2024-07-23
In the country Guided by the "Healthy China 2030" strategy, HealthGen Group actively responded to the national call and is committed to improving the level of primary medical services. Recently, a donation ceremony for chronic disease prevention and treatment to support rural revitalization, jointly organized by HealthGen and Lizhu Pharmaceutical Group, was held at the Gaize County Government Square. Zhang Chengwei, Deputy County Head; Cidan Wangjiu, Director of the County Health and Health Commission; Han Fengyuan, from the County Committee Organization Department (Ali District Committee Organization Department secondment); relevant leaders from the County Health and Health Commission, People's Hospital, and Red Cross Society; presidents of health centers in various townships; and volunteers from HealthGen and Lizhu Group attended the event.

Gaize County, this hot land located in the heart of the Qiangtang Plateau in Tibet, is not only the largest purely pastoral county in the Ali region, but also a place where the red spirit is inherited. In recent years, the Gaize County Committee, guided by the principle of "Tibet Western Pioneer, Red Ali," has promoted the comprehensive development of the economy and society. However, the challenge of chronic high-altitude diseases still exists, affecting the health and well-being of the local people.
In order to effectively improve this situation, Gaize County actively implemented the "County-Township Medical Institution Integration Reform System," significantly improving the level of medical security. This time, the donation of one million yuan worth of medicines from HealthGen and Lizhu Group will be used free of charge to treat low-income chronic disease patients in the area, effectively alleviating their economic burden, improving the health level of local residents, and injecting new impetus into the sustainable development of chronic disease prevention and control work.
According to the "2022 China Health Statistics Yearbook," it is estimated that by 2024, the number of chronic disease patients in China will exceed 500 million, and the proportion of economic burden caused by chronic diseases in the total disease burden will be close to 70%. Chronic diseases are not only the biggest disease burden in China, but also a key challenge to achieving the goal of a healthy China.
HealthGen has always adhered to the mission of "For Health, For Tomorrow," pursuing the organic unity of economic benefits and social benefits. Since the end of 2018, HealthGen's "Inclusive Chronic Disease Prevention and Control Public Welfare Project" has been running for nearly 7 years, its footprints have spread across many provinces and regions across the country, helping nearly 20,000 low-income chronic disease patients solve their medication problems. In addition to donating medicines, HealthGen is also committed to helping patients improve their awareness and ability to manage chronic diseases. Over the years, it has actively carried out public health science education, through health lectures, distribution of science education materials, online patient education activities, and community clinics, linking online and offline efforts to strengthen patients' understanding and management of chronic systemic diseases, and comprehensively improve the effectiveness of patients' chronic disease prevention and control.
In the future, HealthGen will continue to use practical actions to benefit from health dividends and revitalize beautiful villages with corporate strength. While achieving the company's steady and healthy development, it will actively fulfill its social responsibilities, promote chronic disease public welfare projects to go further and deeper, and contribute its "healthy strength" to China's chronic disease prevention and control work.
Quick Navigation
+86 755-33268688 | Service Hotline
Official WeChat Official Account
Copyright © 2025 Joincare Pharmaceutical Group Industry Co., Ltd. ALL Rights Reserve.
COOKIES
Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy
COOKIES
Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy
These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.
These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.
These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.
These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.
Sorry,当前栏目暂无内容!
您可以查看其他栏目或返回 首页
Sorry,The current column has no content!
You can view other columns or return Home